Nearly 90% of patients with an aggressive subtype of non-Hodgkin lymphoma had their cancer go into remission in a small phase 2 clinical trial testing a treatment aimed at making chemotherapy more effective, according to ...
May 4, 2023
0
6
Numerous studies have shown that people from racial and ethnic minority groups are underrepresented in clinical trials of new medical treatments for multiple myeloma. A study published today in the Blood Journal suggests ...
May 4, 2023
0
13
Iron deficiency is one of the five main causes of impaired health. It affects 30 percent of the world's population, particularly women. Why iron deficiency can occur, even if enough iron is supplied through the diet, has ...
Apr 20, 2023
0
1
Children with acute lymphoblastic leukemia (ALL) who live in extreme poverty and were undergoing maintenance therapy faced an almost two-fold greater risk of relapse compared with kids who weren't as poor, according to a ...
Apr 18, 2023
0
2
Even as biomedical engineer Anirban Sen Gupta refines artificial platelets to stem traumatic bleeding, he and his colleagues are seeking new uses for their synthetic solution.
Apr 18, 2023
0
0
For adults with hematologic malignancies receiving chimeric antigen receptor T-cell (CAR-T) therapy, quality of life (QoL) deteriorates and physical and psychological symptoms worsen one week after infusion and then improve ...
Apr 7, 2023
0
18
A landmark discovery linking iron regulation to a rare blood cancer has led to clinical trials of a potential new treatment for patients with the incurable disease.
Apr 4, 2023
0
6
Why do some people with a genetic mutation associated with leukemia remain healthy, while others with the same mutation develop the blood cancer? In a new study published in Blood, scientists from the USC Stem Cell laboratory ...
Mar 23, 2023
1
8
Scientists have found a new way to predict which patients with the blood cancer myeloma will benefit the most from a treatment often used to help keep the disease from coming back after a stem cell transplant.
Mar 20, 2023
0
15
Northwestern Medicine scientists have developed a new tool to help physicians predict the risk of venous thromboembolism in patients with adult-type diffuse gliomas, results published in the journal Blood.
Mar 17, 2023
0
42
